Immunovant, Inc.
IMVT · NASDAQ · USD
$30.26
−1.78 −5.56%todayNot financial advice.
- Open
- 31.40
- Day range
- 29.80 - 31.50
- 52-week range
- 16.60 - 45.42
- Volume
- 1.76M
- Market cap
- 6.25B
- P/E ratio
- —
- EPS
- -2.81
- Dividend yield
- 0.00%
- Beta
- 1.4
Performance
W
−9.83%
1M
−21.59%
3M
−26.37%
6M
+17.61%
YTD
+18.30%
Y
+86.79%
5Y
+238.10%
All
+204.12%
In the news
Oct 8
Argenx Sjogrens Trial Failure Drags Down Immunovant and Roivant Shares
Argenx stopped its late-stage Sjogren’s disease trial, raising doubts about a similar drug class being developed by rival Immunovant.
Company news
Embed on your site
Embed docsAdd a live price card or a chart to any page. Free, no sign-up; cards refresh every minute and link back here.
<iframe src="https://stocks.freetheai.org/embed/NASDAQ-IMVT" width="340" height="170" style="border:0;max-width:100%" loading="lazy" title="Immunovant, Inc. (IMVT) - FreeTheAI Stocks"></iframe>
<p style="font-size:12px"><a href="https://stocks.freetheai.org/symbols/NASDAQ-IMVT">IMVT stock price</a> by FreeTheAI Stocks</p>